This topic contains a solution. Click here to go to the answer

Author Question: When imaging a trauma c-spine, which is necessary for imaging? do nothing leave the patient as they ... (Read 34 times)

DelorasTo

  • Hero Member
  • *****
  • Posts: 548
When imaging a trauma c-spine, which is necessary for imaging?
 
 do nothing leave the patient as they are
  to remove the patient's jewelry that will superimpose anatomy
  remove the patient from the spine board to facilitate better imaging
  remove the patient's c-collar

Question 2

An image that lacks density is said to be:
 
 underexposed
  overpenetrating
  overexposed
  underpenetrated



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sabina576

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

to remove the patient's jewelry that will superimpose anatomy

Rationale: With trauma imaging, the technologist should attempt to remove clothing or jewelry which may obscure essential anatomy. The patient must remain in the c-collar and on the spine board.

Answer to Question 2

underexposed

Rationale: Milliamperage-seconds, mAs, contributes to the overall blackness of the image. It represents the quantity of radiation produced.




DelorasTo

  • Member
  • Posts: 548
Reply 2 on: Jul 17, 2018
:D TYSM


bbburns21

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library